about
Antigen Presentation to Celiac Lesion-Derived T Cells of a 33-Mer Gliadin Peptide Naturally Formed by Gastrointestinal DigestionFc-fusion proteins and FcRn: structural insights for longer-lasting and more effective therapeuticsCarcinoembryonic antigen-related cell adhesion molecule 1 inhibits proximal TCR signaling by targeting ZAP-70Refining the rules of gliadin T cell epitope binding to the disease-associated DQ2 molecule in celiac disease: importance of proline spacing and glutamine deamidationSHP1 phosphatase-dependent T cell inhibition by CEACAM1 adhesion molecule isoformsMolecular characterization of covalent complexes between tissue transglutaminase and gliadin peptides.The preferred substrates for transglutaminase 2 in a complex wheat gluten digest are Peptide fragments harboring celiac disease T-cell epitopesNeonatal Fc receptor: from immunity to therapeuticsNomenclature and listing of celiac disease relevant gluten T-cell epitopes restricted by HLA-DQ molecules.Antigen presentation in celiac disease.An FcRn-dependent role for anti-flagellin immunoglobulin G in pathogenesis of colitis in mice.Immune and non-immune functions of the (not so) neonatal Fc receptor, FcRn.The adaptive immune response in celiac disease.Coeliac disease - from genetic and immunological studies to clinical applications.Small bowel, celiac disease and adaptive immunity.Healthy HLA-DQ2.5+ Subjects Lack Regulatory and Memory T Cells Specific for Immunodominant Gluten Epitopes of Celiac Disease.HLA-DQ molecules as affinity matrix for identification of gluten T cell epitopes.Tetramer-visualized gluten-specific CD4+ T cells in blood as a potential diagnostic marker for coeliac disease without oral gluten challenge.High abundance of plasma cells secreting transglutaminase 2-specific IgA autoantibodies with limited somatic hypermutation in celiac disease intestinal lesions.Epithelial transport and deamidation of gliadin peptides: a role for coeliac disease patient immunoglobulin A.Tissue transglutaminase-mediated formation and cleavage of histamine-gliadin complexes: biological effects and implications for celiac disease.Posttranslational modification of gluten shapes TCR usage in celiac disease.Enzymatic detoxification of gluten by germinating wheat proteases: implications for new treatment of celiac disease.Biased usage and preferred pairing of α- and β-chains of TCRs specific for an immunodominant gluten epitope in coeliac disease.TCR sequencing of single cells reactive to DQ2.5-glia-α2 and DQ2.5-glia-ω2 reveals clonal expansion and epitope-specific V-gene usage.BraCeR: B-cell-receptor reconstruction and clonality inference from single-cell RNA-seqTwo novel HLA-DQ2.5-restricted gluten T cell epitopes in the DQ2.5-glia-γ4 epitope familyResident memory CD8 T cells persist for years in human small intestineEpitope Selection for HLA-DQ2 Presentation: Implications for Celiac Disease and Viral DefenseA molecular basis for the T cell response in HLA-DQ2.2 mediated celiac disease
P50
Q22305469-8A3AF71D-144B-457B-8F1A-8D973A7BC981Q26822421-B2A18922-2958-4EA2-9A36-E76382FBADB8Q28114853-E5D8B531-3AD6-41DD-A63B-5CBD22B55E05Q28257946-C3F59543-F90B-4A1C-BFD2-67B37ECA27D4Q28511516-4E12FB00-7A5D-4616-9637-93E08944A54AQ31038697-F0B1147A-D031-4379-A2B8-144C5829780FQ33761129-A9494C9D-E2B6-405A-B437-E48C63F55CD5Q34268801-D69FDD0C-EC8B-416B-816B-FEAF37AF46CCQ35951955-62BCBA0A-97C8-40C6-BA70-C1F98F39CE9BQ37430981-79B249BA-6E2E-49B9-AA2F-C43A14D60768Q37454723-060D538D-9733-49F6-A9B3-2C45FEB63DE6Q37502056-A0F6EAE8-5099-456A-BB40-86B55E2968CEQ38005620-6FBC1B0A-CB3B-407D-9DD4-C714A709C76CQ38408084-A02471ED-95E9-4AD3-A27D-D80FF41439BCQ38450190-8E4BA219-7554-45A9-BC11-1D0C8C7D670BQ38792554-7BDDD00E-9202-4051-B036-A60BC8C6A329Q38952873-3BEB36EE-BEAD-4A95-9666-7D78C14F7A05Q42108663-FE57E819-79DC-4780-A718-C126614C6225Q42462128-E6C7B2CE-0CC5-42E2-BBD0-ACEEB129DD11Q42482567-C8F6F54A-29DD-47B0-93EA-A027A0CFA628Q45232035-FBF18256-1E37-4DAF-884E-64158809B104Q45263914-F62B1468-1572-4A7B-A240-FAC45D41BB9DQ46057460-BDF42C2F-6AB2-4403-B054-B740FFA7BC25Q53126416-8CDD5CDC-2B21-4B9C-8B20-D2BDC76816E8Q53196123-4CB04BFC-04A5-4155-A5E9-776BBD3BEB63Q57191754-D28CCE3C-7E08-4485-BF63-DF91FDB826CFQ91048274-CDCD7E1B-F557-4DFE-9C51-C06DD55860F7Q92133770-654397B5-784A-4BC6-A5A0-C44DF8C349BFQ92707282-5574BDF6-FDA5-45EB-BA83-2F1AB72E8135Q92889654-664D8468-67C0-4A38-A8C5-0B4E3897EA00
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Shuo-Wang Qiao
@ast
Shuo-Wang Qiao
@de
Shuo-Wang Qiao
@en
Shuo-Wang Qiao
@es
Shuo-Wang Qiao
@fr
Shuo-Wang Qiao
@nds
Shuo-Wang Qiao
@nl
type
label
Shuo-Wang Qiao
@ast
Shuo-Wang Qiao
@de
Shuo-Wang Qiao
@en
Shuo-Wang Qiao
@es
Shuo-Wang Qiao
@fr
Shuo-Wang Qiao
@nds
Shuo-Wang Qiao
@nl
prefLabel
Shuo-Wang Qiao
@ast
Shuo-Wang Qiao
@de
Shuo-Wang Qiao
@en
Shuo-Wang Qiao
@es
Shuo-Wang Qiao
@fr
Shuo-Wang Qiao
@nds
Shuo-Wang Qiao
@nl
P106
P31
P496
0000-0002-0935-8397